Question
Which company developed the gene therapy ITVISMA for spinal muscular atrophy?
Solution
The report mentions that ITVISMA was developed by Novartis, targeting the genetic cause of spinal muscular atrophy.
More Beepedia Questions
- Who won the gold medal in the Women's category at the Asian Individual Chess Championship 2026?
- The Scheme for Sustainable Structuring of Stressed Assets (S4A) is the latest measure taken by the ________ to tackle stressed assets.
- In test match cricket, how many minimum overs can a team play in a day?
- The VSHORADS missile system belongs to which category of weapon systems?
- How many Commonwealth parliaments are expected to participate in the 28th CSPOC?
- When is World Sustainable Transport Day designated by the UN General Assembly every year?
- Who is willful defaulter?
- As per the updated protocol, when both are performed at an event, which should be played or sung first?
- When will the ICAR Annual Conference of Vice-Chancellors and Directors be held in 2025?
- What is the purpose of the agreement signed between the Reserve Bank of India (RBI) and the Bank of Mauritius during the Prime Minister's visit to Mauritiu...
Relevant for Exams:
